Epigenetic mechanisms regulating normal and malignant haematopoiesis: new therapeutic targets for clinical medicine
- PMID: 20152067
- DOI: 10.1017/S1462399410001377
Epigenetic mechanisms regulating normal and malignant haematopoiesis: new therapeutic targets for clinical medicine
Abstract
It is now well established that epigenetic phenomena and aberrant gene regulation play a major role in carcinogenesis. These include aberrant gene silencing by imposing inactive histone marks on promoters, aberrant methylation of DNA at CpG islands, and the active repression of promoters by oncoproteins. In addition, many malignant cells also show aberrant gene activation due to constitutively active signalling. The next frontier in cancer research will be to examine how, at the molecular level, small mutations that alter the regulatory phenotype of a cell give rise after a number of cell divisions to the vast deregulation phenomena seen in malignant cells. This review outlines recent insights into how normal cell differentiation in the haematopoietic system is subverted in leukaemia and it introduces the molecular players involved in this process. It also summarises the results of recent clinical trials trying to reverse aberrant epigenetic regulation by employing agents influencing global epigenetic regulators.
Similar articles
-
Epigenetic regulation of normal and malignant hematopoiesis.Oncogene. 2007 Oct 15;26(47):6697-714. doi: 10.1038/sj.onc.1210755. Oncogene. 2007. PMID: 17934479 Review.
-
Epigenetics in Hematological Malignancies.Methods Mol Biol. 2018;1856:87-101. doi: 10.1007/978-1-4939-8751-1_5. Methods Mol Biol. 2018. PMID: 30178247 Review.
-
DNA methylation in normal and malignant hematopoiesis.Int J Hematol. 2016 Jun;103(6):617-26. doi: 10.1007/s12185-016-1957-7. Epub 2016 Mar 4. Int J Hematol. 2016. PMID: 26943352 Review.
-
Epigenetics in normal and malignant hematopoiesis: An overview and update 2017.Cancer Sci. 2017 Apr;108(4):553-562. doi: 10.1111/cas.13168. Epub 2017 Apr 20. Cancer Sci. 2017. PMID: 28100030 Free PMC article. Review.
-
Epigenetics of hematopoiesis and hematological malignancies.Genes Dev. 2016 Sep 15;30(18):2021-2041. doi: 10.1101/gad.284109.116. Genes Dev. 2016. PMID: 27798847 Free PMC article. Review.
Cited by
-
Burn injury dampens erythroid cell production through reprioritizing bone marrow hematopoietic response.J Trauma. 2011 Nov;71(5):1288-96. doi: 10.1097/TA.0b013e31822e2803. J Trauma. 2011. PMID: 22071930 Free PMC article.
-
MicroRNAs Involved in Anti-Tumour Immunity.Int J Mol Sci. 2013 Mar 11;14(3):5587-607. doi: 10.3390/ijms14035587. Int J Mol Sci. 2013. PMID: 23478435 Free PMC article.
-
Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding.Leukemia. 2012 Aug;26(8):1829-41. doi: 10.1038/leu.2012.49. Epub 2012 Feb 20. Leukemia. 2012. PMID: 22343733 Free PMC article.
-
Subtype-specific regulatory network rewiring in acute myeloid leukemia.Nat Genet. 2019 Jan;51(1):151-162. doi: 10.1038/s41588-018-0270-1. Epub 2018 Nov 12. Nat Genet. 2019. PMID: 30420649 Free PMC article.
-
Developmental-stage-dependent transcriptional response to leukaemic oncogene expression.Nat Commun. 2015 May 28;6:7203. doi: 10.1038/ncomms8203. Nat Commun. 2015. PMID: 26018585 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources